Monteuuis, G;
Awadhpersad, R;
van der Kolk, D;
Singh, SK;
Nyman, TA;
Malyutina, A;
Zamboni, N;
Moisio, K;
Juutila, J;
Hietakangas, V;
et al.
Monteuuis, G; Awadhpersad, R; van der Kolk, D; Singh, SK; Nyman, TA; Malyutina, A; Zamboni, N; Moisio, K; Juutila, J; Hietakangas, V; Seneca, S; Carroll, CJ; Jackson, CB
(2025)
Vacuolar-type H+-ATPase-mediated extra-organellar buffering resolves mitochondrial dysfunction.
Nature Communications, 17.
p. 67.
ISSN 2041-1723
https://doi.org/10.1038/s41467-025-66656-1
SGUL Authors: Carroll, Christopher John
|
PDF
Published Version
Available under License Creative Commons Attribution. Download (5MB) |
|
|
PDF (Supplementary Information)
Supporting information
Download (43MB) |
|
|
PDF (Reporting Summary)
Supporting information
Download (2MB) |
|
|
PDF (Transparent Peer Review file)
Supporting information
Download (7MB) |
Abstract
Mitochondrial dysfunction underlies a wide range of human diseases, including primary mitochondrial disorders, neurodegeneration, cancer, and ageing. To preserve cellular homeostasis, organisms have evolved adaptive mechanisms that coordinate nuclear and mitochondrial gene expression. Here, we use genome-wide CRISPR knockout screening to identify cell fitness pathways that support survival under impaired mitochondrial protein synthesis. The strongest suppressor of aberrant mitochondrial translation defects – besides a compendium of known mitochondrial translation quality control factors – is the loss of the vacuolar-type H + -ATPase (v-ATPase), a key regulator of intracellular acidification, nutrient sensing, and growth signaling. We show that partial v-ATPase loss reciprocally modulates mitochondrial membrane potential (ΔΨ m ) and cristae structure in both cancer cell lines and mitochondrial disease patient-derived models. Our findings uncover an extra-organellar buffering mechanism whereby partial v-ATPase inhibition mitigates mitochondrial dysfunction by altering pH homeostasis and driving metabolic rewiring as a protective response that promotes cell fitness.
| Item Type: | Article | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Information: | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. © The Author(s) 2025 | ||||||||||||||||||
| SGUL Research Institute / Research Centre: | Academic Structure > Cardiovascular & Genomics Research Institute Academic Structure > Cardiovascular & Genomics Research Institute > Genomics |
||||||||||||||||||
| Journal or Publication Title: | Nature Communications | ||||||||||||||||||
| ISSN: | 2041-1723 | ||||||||||||||||||
| Language: | en | ||||||||||||||||||
| Media of Output: | Print-Electronic | ||||||||||||||||||
| Related URLs: | |||||||||||||||||||
| Publisher License: | Creative Commons: Attribution 4.0 | ||||||||||||||||||
| Projects: |
|
||||||||||||||||||
| PubMed ID: | 41339359 | ||||||||||||||||||
| Dates: |
|
||||||||||||||||||
| Go to PubMed abstract | |||||||||||||||||||
| URI: | https://openaccess.sgul.ac.uk/id/eprint/118145 | ||||||||||||||||||
| Publisher's version: | https://doi.org/10.1038/s41467-025-66656-1 |
Statistics
Actions (login required)
![]() |
Edit Item |

